Cytokine profiles of bronchoalveolar lavage fluid in patients with pneumocystis pneumonia

Microbiology and Immunology

Volumn 54, Issue 7, 2010, Pages 425-433

  Tasaka, Sadatomo ^a   Kobayashi, Seiki ^a   Kamata, Hirofumi ^a   Kimizuka, Yoshifumi ^a   Fujiwara, Hiroshi ^a   Funatsu, Yohei ^a   Mizoguchi, Kosuke ^a   Ishii, Makoto ^a   Takeuchi, Tsutomu ^a   Hasegawa, Naoki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acquired immunodeficiency syndrome; Bronchoalveolar lavage; Cytokine; Pneumocystis pneumonia

Indexed keywords

BETA GLUCAN; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD OXYGENATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MALE; MEDICAL RECORD REVIEW; NEUTROPHIL COUNT; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; UPREGULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AUTOIMMUNE DISEASES; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LUNG; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES;

PNEUMOCYSTIS;

EID: 77954475111     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2010.00229.x     Document Type: Article

References (29)

1. Thomas Jr. C.F., Limper A.H. (2004) Pneumocystis pneumonia. N Engl J Med 350: 2487-98.
2. Yale S.H., Limper A.H. (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71: 5-13.
3. Sepkowitz K.A. (2002) Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 34: 1098-107.
4. Kovacs J.A., Hiemenz J.W., Macher A.M., Stover D., Murray H.W., Shelhamer J., Lane H.C., Urmacher C., Honig C., Longo D.L. (1984) Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100: 663-71.
5. Sepkowitz K.A., Brown A.E., Telzak E.E., Gottlieb S., Armstrong D. (1992) Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 267: 832-7.
6. Limper A.H., Offord K.P., Smith T.F., Martin II W.J. (1989) Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140: 1204-9.
7. Tokuda H., Sakai F., Yamada H., Johkoh T., Imamura A., Dohi M., Hirakata M., Yamada T., Kamatani N., Kikuchi Y., Sugii S., Takeuchi T., Tateda K., Goto H. (2008) Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study. Intern Med 47: 915-23.
8. Tasaka S., Tokuda H., Sakai F., Fujii T., Tateda K., Johkoh T., Ohmagari N., Ohta H., Araoka H., Kikuchi Y., Yasui M., Inuzuka K., Goto H. (2010) Comparison of clinical and radiological features of pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study. Intern Med 49: 273-81.
9. Benfield T.L., Lundgren B., Shelhamer J.H., Lundgren J.D. (1999) Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-1 release from a human alveolar epithelial cell line. Eur J Clin Invest 29: 717-22.
10. Pottratz S.T., Reese S., Sheldon J.L. (1998) Pneumocystis carinii induces interleukin 6 production by an alveolar epithelial cell line. Eur J Clin Invest 28: 424-9.
11. Israël-Biet D., Esvant H., Laval A.M., Cadranel J. (2004) Impairment of β chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia. Thorax 59: 247-51.
12. Benfield T.L., Vestbo J., Junge J., Nielsen T.L., Jensen A.B., Lundgren J.D. (1995) Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 151: 1058-62.
13. Suga M., Iyonaga K., Ichiyasu H., Saita N., Yamasaki H., Ando M. (1999) Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 14: 376-82.
14. Wang J., Gigliotti F., Bhagwat S.P., Maggirwar S.B., Wright T.W. (2007) Pneumocystis stimulates MCP-1 production by alveolar epithelial cells through a JNK-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 292: L1495-505.
15. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-51.
16. Ueno H., Matsuda T., Hashimoto S., Amaya F., Kitamura Y., Tanaka M., Kobayashi A., Maruyama I., Yamada S., Hasegawa N., Soejima J., Koh H., Ishizaka A. (2004) Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 170: 1310-6.
17. van Zoelen M.A.D., Laterre P.F., van Veen S.Q., van Till J.W., Wittebole X., Bresser P., Tanck M.W., Dugernier T., Ishizaka A., Boermeester M.A., van der Poll T. (2007) Systemic and local high mobility group box 1 concentrations during severe infection. Crit Care Med 35: 2799-804.
18. Wright T.W., Gigliotti F., Finkelstein J.N., McBride J.T., An C.L., Harmsen A.G. (1999) Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 104: 1307-17.
19. Mason G.R., Hashimoto C.H., Dickman P.S., Foutty L.F., Cobb C.J. (1989) Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 139: 1336-42.
20. Chollet-Martin S., Montravers P., Gibert C., Elbim C., Desmonts J.M., Fagon J.Y., Gougerot-Pocidalo M.A. (1993) High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 61: 4553-9.
21. Sibila O., Agustí C., Torres A., Baquero S., Gando S., Patrón J.R., Morato J.G., Goffredo D.H., Bassi N., Luna C. (2007) Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response. Eur Respir J 30: 1167-72.
22. Fujimori Y., Kataoka M., Tada S., Takehara H., Matsuo K., Miyake T., Okahara M., Yamadori I., Tanimoto M. (2003) The role of interleukin-8 in interstitial pneumonia. Respirology 8: 33-40.
23. Schmidt K., Martinez-Gamboa L., Meier S., Witt C., Meisel C., Hanitsch L.G., Becker M.O., Huscher D., Burmester G.R., Riemekasten G. (2009) Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients. Arthritis Res Ther 11: R111.
24. Tasaka S., Hasegawa N., Kobayashi S., Yamada W., Nishimura T., Takeuchi T., Ishizaka A. (2007) Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest 131: 1173-80.
25. Quist J., Hill A.R. (1995) Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis, and bacterial pneumonia. Chest 108: 415-8.
26. Wang J., Gigliotti F., Maggirwar S., Johnston C., Finkelstein J.N., Wright T.W. (2005) Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Infect Immun 73: 2766-77.
27. Pahl H.L. (1999) Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853-66.
28. Vassallo R., Standing J.E., Limper A.H. (2000) Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J Immunol 164: 3755-63.
29. Evans S.E., Hahn P.Y., McCann F., Kottom T.J., Pavlovic Z.V., Limper A.H. (2005) Pneumocystis cell wall β-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-κB-dependent mechanisms. Am J Respir Cell Mol Biol 32: 490-7.